Does the media prefer FMS or DGX?

In the previous week, Fresenius Medical Care AG & Co. KGaA and Fresenius Medical Care AG & Co. KGaA both had 3 articles in the media. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.70 beat Quest Diagnostics' score of 0.44 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quest Diagnostics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to LH or FMS?

In the previous week, Labcorp had 3 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 6 mentions for Labcorp and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.70 beat Labcorp's score of 0.41 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to FMS or TEM?

In the previous week, Tempus AI had 10 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 13 mentions for Tempus AI and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Tempus AI's average media sentiment score of 0.77 beat Fresenius Medical Care AG & Co. KGaA's score of 0.70 indicating that Tempus AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tempus AI 5 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer DVA or FMS?

In the previous week, DaVita had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 4 mentions for DaVita and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.70 beat DaVita's score of 0.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DaVita 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

$22.28 +0.02 (+0.07%)

Closing price 10/2/2026 03:59 PM Eastern

Extended Trading

$22.26 -0.02 (-0.09%)

As of 10/2/2026 07:30 PM Eastern

Compare

FMS vs. DGX, LH, GH, TEM, and DVA

Should you buy Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? Fresenius Medical Care AG & Co. KGaA's main competitors and comparable companies include Quest Diagnostics (DGX), Labcorp (LH), Guardant Health (GH), Tempus AI (TEM), and DaVita (DVA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Fresenius Medical Care AG & Co. KGaA compare to Quest Diagnostics?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Quest Diagnostics (NYSE:DGX) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

Fresenius Medical Care AG & Co. KGaA currently has a consensus target price of $23.68, indicating a potential upside of 6.29%. Quest Diagnostics has a consensus target price of $237.08, indicating a potential upside of 1.61%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, equities analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Quest Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.58
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54

In the previous week, Fresenius Medical Care AG & Co. KGaA and Fresenius Medical Care AG & Co. KGaA both had 3 articles in the media. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.70 beat Quest Diagnostics' score of 0.44 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quest Diagnostics	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market.

Quest Diagnostics has a net margin of 9.18% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Quest Diagnostics' return on equity of 16.01% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
Quest Diagnostics	9.18%	16.01%	7.27%

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.61 per share and has a dividend yield of 2.7%. Quest Diagnostics pays an annual dividend of $3.44 per share and has a dividend yield of 1.5%. Fresenius Medical Care AG & Co. KGaA pays out 31.6% of its earnings in the form of a dividend. Quest Diagnostics pays out 36.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Quest Diagnostics has increased its dividend for 14 consecutive years. Fresenius Medical Care AG & Co. KGaA is clearly the better dividend stock, given its higher yield and lower payout ratio.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Quest Diagnostics. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.54
Quest Diagnostics	$11.04B	2.33	$992M	$9.42	24.77

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 0.9% of Quest Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Quest Diagnostics beats Fresenius Medical Care AG & Co. KGaA on 12 of the 19 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Labcorp?

Labcorp (NYSE:LH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

In the previous week, Labcorp had 3 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 6 mentions for Labcorp and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.70 beat Labcorp's score of 0.41 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Labcorp	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Labcorp pays an annual dividend of $2.88 per share and has a dividend yield of 0.9%. Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.61 per share and has a dividend yield of 2.7%. Labcorp pays out 23.8% of its earnings in the form of a dividend. Fresenius Medical Care AG & Co. KGaA pays out 31.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Labcorp has a net margin of 6.99% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Labcorp's return on equity of 16.74% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Labcorp	6.99%	16.74%	7.81%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Labcorp. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$13.95B	1.79	$876.50M	$12.09	25.52
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.54

Labcorp presently has a consensus price target of $337.73, indicating a potential upside of 9.45%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.68, indicating a potential upside of 6.29%. Given Labcorp's stronger consensus rating and higher possible upside, research analysts plainly believe Labcorp is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.58

Labcorp has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market.

95.9% of Labcorp shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 0.8% of Labcorp shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Labcorp beats Fresenius Medical Care AG & Co. KGaA on 14 of the 18 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

Guardant Health currently has a consensus target price of $188.54, indicating a potential upside of 6.04%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.68, indicating a potential upside of 6.29%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.58

In the previous week, Guardant Health had 3 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 6 mentions for Guardant Health and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.70 beat Guardant Health's score of 0.62 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Guardant Health's net margin of -38.33%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	24.30	-$416.28M	-$3.49	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.54

Guardant Health has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

Summary

Fresenius Medical Care AG & Co. KGaA beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Tempus AI?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Tempus AI (NASDAQ:TEM) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.54
Tempus AI	$1.27B	10.87	-$245.03M	-$1.44	N/A

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 24.2% of Tempus AI shares are owned by institutional investors. 24.3% of Tempus AI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $23.68, indicating a potential upside of 6.29%. Tempus AI has a consensus price target of $71.05, indicating a potential downside of 7.28%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, research analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.58
Tempus AI	2 Sell rating(s)	9 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.41

Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market. Comparatively, Tempus AI has a beta of 3.54, meaning that its share price is 254% more volatile than the broader market.

In the previous week, Tempus AI had 10 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 13 mentions for Tempus AI and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Tempus AI's average media sentiment score of 0.77 beat Fresenius Medical Care AG & Co. KGaA's score of 0.70 indicating that Tempus AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tempus AI	5 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Tempus AI's net margin of -17.77%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
Tempus AI	-17.77%	-50.28%	-10.33%

Summary

Fresenius Medical Care AG & Co. KGaA and Tempus AI tied by winning 8 of the 16 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to DaVita?

DaVita (NYSE:DVA) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

DaVita has a net margin of 6.05% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	6.05%	-217.63%	5.07%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than DaVita. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$13.64B	0.84	$746.80M	$12.22	14.62
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.54

DaVita has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

DaVita presently has a consensus price target of $233.43, indicating a potential upside of 30.66%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.68, indicating a potential upside of 6.29%. Given DaVita's stronger consensus rating and higher probable upside, analysts clearly believe DaVita is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.58

90.1% of DaVita shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 1.9% of DaVita shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, DaVita had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 4 mentions for DaVita and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.70 beat DaVita's score of 0.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DaVita beats Fresenius Medical Care AG & Co. KGaA on 12 of the 16 factors compared between the two stocks.

Get Fresenius Medical Care AG & Co. KGaA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FMS vs. The Competition

Export

Metric	Fresenius Medical Care AG & Co. KGaA	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$11.96B	$9.59B	$7.14B	$22.64B
Dividend Yield	2.72%	2.61%	2.53%	3.73%
P/E Ratio	11.54	34.21	275.68	27.75
Price / Sales	0.54	5.39	661.92	96.41
Price / Cash	4.00	120.59	77.60	38.88
Price / Book	0.77	5.15	10.93	4.64
Net Income	$1.11B	$315.68M	$3.51B	$1.08B
7 Day Performance	-1.85%	-2.59%	-2.00%	-1.06%
1 Month Performance	-0.78%	-3.19%	-6.15%	-5.49%
1 Year Performance	-16.74%	7.93%	7.44%	5.13%

Fresenius Medical Care AG & Co. KGaA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FMS Fresenius Medical Care AG & Co. KGaA	3.0972 of 5 stars	$22.28 +0.1%	$23.68 +6.3%	-16.4%	$11.96B	$22.20B	11.54	1,488	Analyst Downgrade
DGX Quest Diagnostics	3.8283 of 5 stars	$244.81 -0.7%	$237.08 -3.2%	+29.0%	$27.20B	$11.04B	25.99	57,000
LH Labcorp	4.0666 of 5 stars	$321.27 +0.2%	$337.73 +5.1%	+10.6%	$26.01B	$13.95B	26.57	71,000
GH Guardant Health	2.1758 of 5 stars	$173.87 -3.1%	$188.13 +8.2%	+189.3%	$24.07B	$982.02M	N/A	2,506	Analyst Forecast
TEM Tempus AI	1.7973 of 5 stars	$78.03 +0.2%	$69.63 -10.8%	-14.2%	$14.05B	$1.27B	N/A	3,800	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:FMS) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

FMS vs. DGX, LH, GH, TEM, and DVA

How does Fresenius Medical Care AG & Co. KGaA compare to Quest Diagnostics?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Labcorp?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Tempus AI?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to DaVita?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FMS vs. The Competition

Fresenius Medical Care AG & Co. KGaA Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

FMS vs. DGX, LH, GH, TEM, and DVA

How does Fresenius Medical Care AG & Co. KGaA compare to Quest Diagnostics?

Do analysts prefer FMS or DGX?

Does the media prefer FMS or DGX?

Which has more risk & volatility, FMS or DGX?

Is FMS or DGX more profitable?

Is FMS or DGX a better dividend stock?

Which has preferable valuation and earnings, FMS or DGX?

Do institutionals & insiders have more ownership in FMS or DGX?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Labcorp?

Does the media refer more to LH or FMS?

Is LH or FMS a better dividend stock?

Is LH or FMS more profitable?

Which has better valuation & earnings, LH or FMS?

Do analysts recommend LH or FMS?

Which has more volatility & risk, LH or FMS?

Do insiders and institutionals hold more shares of LH or FMS?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Do analysts rate GH or FMS?

Does the media prefer GH or FMS?

Is GH or FMS more profitable?

Do insiders and institutionals have more ownership in GH or FMS?

Which has preferable valuation and earnings, GH or FMS?

Which has more risk and volatility, GH or FMS?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Tempus AI?

Which has preferable earnings and valuation, FMS or TEM?

Do insiders & institutionals have more ownership in FMS or TEM?

Do analysts recommend FMS or TEM?

Which has more risk and volatility, FMS or TEM?

Does the media refer more to FMS or TEM?

Is FMS or TEM more profitable?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to DaVita?

Is DVA or FMS more profitable?

Which has better valuation and earnings, DVA or FMS?

Which has more risk & volatility, DVA or FMS?

Do analysts rate DVA or FMS?

Do institutionals and insiders believe in DVA or FMS?

Does the media prefer DVA or FMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FMS vs. The Competition

Fresenius Medical Care AG & Co. KGaA Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools